You are here: All Products  > GeneScience Acquires Rights to Prostate Cancer Therapy in $132 Million Agreement

GeneScience Acquires Rights to Prostate Cancer Therapy in $132 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products